Carboplatin (Paraplatin)
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Carboplatin (Paraplatin), covering 2009-12-15 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer [Phase 3]